L609-1322 Screening compound: 3-[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,4-dimethoxyphenyl)propanamide

L609-1322 Screening compound: 3-[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,4-dimethoxyphenyl)propanamide
L609-1322 Screening compound: 3-[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,4-dimethoxyphenyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L609-1322
3-[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,4-dimethoxyphenyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L609-1322

Molecular Formula

C24H22BrN3O3 (C24 H22 BrN3 O3)

Compound Name

3-[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,4-dimethoxyphenyl)propanamide

IUPAC name

3-[2-(4-bromophenyl)imidazo[12-a]pyridin-3-yl]-N-(34-dimethoxyphenyl)propanamide

SMILES

COc(ccc(NC(CCc1c(-c(cc2)ccc2Br)nc2n1cccc2)=O)c1)c1OC

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.36

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.224

Distribution Coefficient, logD

4.222

Water Solubility, LogSw

-4.39

Polar Surface Area

46.743

Acid Dissociation Constant (pKa)

10.95

Base Dissociation Constant (pKb)

5.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

L609-1322 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L609-1322 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L609-1322?
Check Price and Availability of L609-1322, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L609-1322 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L609-1322
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L609-1322
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L609-1322 available by request